Ginsenoside Rd
Ginsenoside Rd inhibits TNFα-induced NF-κB transcriptional activity with an IC50 of 12.05±0.82 μM in HepG2 cells. Ginsenoside Rd inhibits expression of COX-2 and iNOS mRNA. Ginsenoside Rd also inhibits Ca2+ influx. Ginsenoside Rd inhibits CYP2D6, CYP1A2, CYP3A4, and CYP2C9, with IC50s of 58.0±4.5 μM, 78.4±5.3 μM, 81.7±2.6 μM, and 85.1±9.1 μM, respectively.
Product Specifications
CAS Number
[52705-93-8]
Product Name Alternative
Gypenoside VIII
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Calcium Channel; COX; Cytochrome P450; Endogenous Metabolite; NF-κB
Type
Natural Products
Related Pathways
Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/Ginsenoside-Rd.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C48H82O18
Molecular Weight
947.15
Precautions
H302, H315, H319, H335
References & Citations
2+Min/+
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
COX-2; CYP1; CYP2; CYP3; L-type calcium channel; NF-κB
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items